The American Heart Association (AHA), endorsed by the American Academy of Pediatrics (AAP), identified 8 high-risk pediatric diagnosis and developed practical recommendations for the management of cardiovascular risk.. The selected diseases comprise familial hypercholesterolemia (FH), together with diabetes mellitus (type 1 and 2), chronic kidney disease, heart transplantation, Kawasaki disease, congenital heart disease, chronic inflammatory disease and childhood cancer. Subclinical endothelia dysfunction, measured through non-invasive surrogate methods such as flow-mediated dilation (FMD), occurs early in FH children indicating an increased risk for premature CVD and reflecting the need for early initiation of anticholesterolemic treatment. Moreover, increasing evidences indicate that, in high-risk conditions as well as in most children with a minor degree of vascular involvement, appropriate therapy could prevent and/or reverse the progression of these cardiovascular changes]. Therefore, the identification and the management of hypercholesterolemia in children are of great consequence.

Hypercholesterolemia in Childhood / Iughetti, Lorenzo; Predieri, Barbara; Bruzzi, Patrizia. - ELETTRONICO. - (2015), pp. 33-54. [10.5772/59760]

Hypercholesterolemia in Childhood

IUGHETTI, Lorenzo;PREDIERI, Barbara;BRUZZI, Patrizia
2015

Abstract

The American Heart Association (AHA), endorsed by the American Academy of Pediatrics (AAP), identified 8 high-risk pediatric diagnosis and developed practical recommendations for the management of cardiovascular risk.. The selected diseases comprise familial hypercholesterolemia (FH), together with diabetes mellitus (type 1 and 2), chronic kidney disease, heart transplantation, Kawasaki disease, congenital heart disease, chronic inflammatory disease and childhood cancer. Subclinical endothelia dysfunction, measured through non-invasive surrogate methods such as flow-mediated dilation (FMD), occurs early in FH children indicating an increased risk for premature CVD and reflecting the need for early initiation of anticholesterolemic treatment. Moreover, increasing evidences indicate that, in high-risk conditions as well as in most children with a minor degree of vascular involvement, appropriate therapy could prevent and/or reverse the progression of these cardiovascular changes]. Therefore, the identification and the management of hypercholesterolemia in children are of great consequence.
2015
Hypercholesterolemia
Kumar, Ashok N.
9789535121695
INTECH
Hypercholesterolemia in Childhood / Iughetti, Lorenzo; Predieri, Barbara; Bruzzi, Patrizia. - ELETTRONICO. - (2015), pp. 33-54. [10.5772/59760]
Iughetti, Lorenzo; Predieri, Barbara; Bruzzi, Patrizia
File in questo prodotto:
File Dimensione Formato  
capitolo finale.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 238.64 kB
Formato Adobe PDF
238.64 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1072051
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact